{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:53:46Z","timestamp":1787756026459,"version":"build-2784847793"},"reference-count":136,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:00:00Z","timestamp":1761350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Arrhythmogenic cardiomyopathy (ACM) is a genetic cardiac disease characterized by a progressive loss of cardiomyocytes associated with fibrofatty myocardial replacement, resulting in a heightened risk of ventricular arrhythmias and sudden cardiac death. ACM is a common cause of sudden death in young individuals, and exercise has been proven to be a factor in disease progression. Current therapeutic strategies, including lifestyle modification, antiarrhythmic pharmacological therapy, catheter ablation, and the placement of implantable cardioverter-defibrillators, remain primarily palliative options rather than addressing the underlying molecular substrate. The pathogenesis of ACM includes complex molecular and cellular mechanisms, linking genetic mutations to structural and electrical anomalies of the ventricle. The lack of targeted therapies contributes to a challenging approach to the disease. It highlights the need for a better understanding of the mechanisms that lead to myocardial remodeling and arrhythmic predisposition. With the help of animal models (especially murine) and induced pluripotent stem cells, there have been advances in understanding the molecular pathogenesis of ACM. In this review, we summarized some of the pathogenic molecular pathways involved in the development of ACM and emerging therapies targeted towards disease modification, not just prevention.<\/jats:p>","DOI":"10.3390\/biom15111512","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:50:48Z","timestamp":1761533448000},"page":"1512","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Molecular Pathogenesis of Arrhythmogenic Cardiomyopathy: Mechanisms and Therapeutic Perspectives"],"prefix":"10.3390","volume":"15","author":[{"given":"Eliza","family":"Popa","sequence":"first","affiliation":[{"name":"National Institute of Legal Medicine, 042122 Bucharest, Romania"},{"name":"Department of Legal Medicine and Bioethics, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4130-9402","authenticated-orcid":false,"given":"Sorin","family":"Hostiuc","sequence":"additional","affiliation":[{"name":"National Institute of Legal Medicine, 042122 Bucharest, Romania"},{"name":"Department of Legal Medicine and Bioethics, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/CIRCRESAHA.117.309345","article-title":"Arrhythmogenic cardiomyopathy","volume":"121","author":"Corrado","year":"2017","journal-title":"Circ. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijcard.2020.06.005","article-title":"Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria","volume":"319","author":"Corrado","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198801213180301","article-title":"Right ventricular cardiomyopathy and sudden death in young people","volume":"318","author":"Thiene","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s12551-018-0437-0","article-title":"Genetics of and pathogenic mechanisms in arrhythmogenic right ventricular cardiomyopathy","volume":"10","author":"Vimalanathan","year":"2018","journal-title":"Biophys. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/S0140-6736(09)60256-7","article-title":"Arrhythmogenic right ventricular cardiomyopathy","volume":"373","author":"Basso","year":"2009","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"131602","DOI":"10.1016\/j.ijcard.2023.131602","article-title":"Basic and translational mechanisms in inflammatory arrhythmogenic cardiomyopathy","volume":"397","author":"Engel","year":"2024","journal-title":"Int. J. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Kochi, A.N., Vettor, G., Dessanai, M.A., Pizzamiglio, F., and Tondo, C. (2021). Sudden cardiac death in athletes: From the basics to the practical work-up. Medicina, 57.","DOI":"10.3390\/medicina57020168"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0008-6363(01)00254-1","article-title":"Sudden cardiac death in young people with apparently normal heart","volume":"50","author":"Corrado","year":"2001","journal-title":"Cardiovasc. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jacc.2013.06.033","article-title":"Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated desmosomal mutation carriers","volume":"62","author":"James","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"101799","DOI":"10.1016\/j.cpcardiol.2023.101799","article-title":"Arrhythmogenic cardiomyopathy and athletes: A dangerous relationship","volume":"48","author":"Grazioli","year":"2023","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41569-019-0200-7","article-title":"Molecular mechanisms of arrhythmogenic cardiomyopathy","volume":"16","author":"Austin","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40303-015-0010-8","article-title":"Effects of physical exercise on central nervous system functions: A review of brain region specific adaptations","volume":"3","author":"Morgan","year":"2015","journal-title":"J. Mol. Psychiatry"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"eabf0891","DOI":"10.1126\/scitranslmed.abf0891","article-title":"Exercise triggers CAPN1-mediated AIF truncation, inducing myocyte cell death in arrhythmogenic cardiomyopathy","volume":"13","author":"Chelko","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Hammer, K.P., Mustroph, J., Stauber, T., Birchmeier, W., Wagner, S., and Maier, L.S. (2021). Beneficial effect of voluntary physical exercise in Plakophilin2 transgenic mice. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0252649"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2015.10.030","article-title":"Role of connexin 43 in cardiovascular diseases","volume":"768","author":"Pecoraro","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Coscarella, I.L., Landim-Vieira, M., Pinto, J.R., and Chelko, S.P. (2022). Arrhythmogenic Cardiomyopathy: Exercise pitfalls, role of Connexin-43, and moving beyond antiarrhythmics. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158753"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.yjmcc.2016.01.023","article-title":"Moderate intensity exercise prevents diabetic cardiomyopathy associated contractile dysfunction through restoration of mitochondrial function and connexin 43 levels in db\/db mice","volume":"92","author":"Veeranki","year":"2016","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.yjmcc.2017.06.005","article-title":"Exercise training intensity and connexin 43 expression in hypertrophic cardiomyopathy","volume":"109","author":"Malkani","year":"2017","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_19","first-page":"1","article-title":"Exhaustive exercise-induced cardiac conduction system injury and changes of cTnT and Cx43","volume":"36","author":"Chang","year":"2015","journal-title":"Int. J. Sports Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1161\/01.CIR.101.11.e101","article-title":"Arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"101","author":"Corrado","year":"2000","journal-title":"Circulation"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.tcm.2020.07.006","article-title":"Arrhythmogenic cardiomyopathy: An in-depth look at molecular mechanisms and clinical correlates","volume":"31","author":"Costa","year":"2021","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jacc.2018.05.065","article-title":"Clinical diagnosis, imaging, and genetics of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: JACC state-of-the-art review","volume":"72","author":"Gandjbakhch","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/CIRCRESAHA.110.223412","article-title":"The cardiac desmosome and arrhythmogenic cardiomyopathies: From gene to disease","volume":"107","author":"Delmar","year":"2010","journal-title":"Circ. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"131447","DOI":"10.1016\/j.ijcard.2023.131447","article-title":"Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report","volume":"395","author":"Corrado","year":"2024","journal-title":"Int. J. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Patel, V., Asatryan, B., Siripanthong, B., Munroe, P.B., Tiku-Owens, A., Lopes, L.R., Khanji, M.Y., Protonotarios, A., Santangeli, P., and Muser, D. (2020). State of the art review on genetics and precision medicine in arrhythmogenic cardiomyopathy. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186615"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"90","DOI":"10.15420\/AER.2016.4.3","article-title":"Arrhythmogenic cardiomyopathy: Electrical and structural phenotypes","volume":"5","author":"Akdis","year":"2016","journal-title":"Arrhythm. Electrophysiol. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Varrenti, M., Preda, A., Frontera, A., Baroni, M., Gigli, L., Vargiu, S., Colombo, G., Carbonaro, M., Paolucci, M., and Giordano, F. (2024). Arrhythmogenic cardiomyopathy: Definition, classification and arrhythmic risk stratification. J. Clin. Med., 13.","DOI":"10.3390\/jcm13020456"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Bariani, R., Rigato, I., Cason, M., Marinas, M.B., Celeghin, R., Pilichou, K., and Bauce, B. (2022). Genetic background and clinical features in arrhythmogenic left ventricular cardiomyopathy: A systematic review. J. Clin. Med., 11.","DOI":"10.3390\/jcm11154313"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Mattesi, G., Cipriani, A., Bauce, B., Rigato, I., Zorzi, A., and Corrado, D. (2021). Arrhythmogenic left ventricular cardiomyopathy: Genotype-phenotype correlations and new diagnostic criteria. J. Clin. Med., 10.","DOI":"10.3390\/jcm10102212"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.4330\/wjc.v6.i12.1234","article-title":"Arrhythmogenic right ventricular cardiomyopathy: From genetics to diagnostic and therapeutic challenges","volume":"6","author":"Pinamonti","year":"2014","journal-title":"World J. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Stevens, T.L., Wallace, M.J., Refaey, M.E., Roberts, J.D., Koenig, S.N., and Mohler, P.J. (2020). Arrhythmogenic cardiomyopathy: Molecular insights for improved therapeutic design. J. Cardiovasc. Dev. Dis., 7.","DOI":"10.3390\/jcdd7020021"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Delva, E., Tucker, D.K., and Kowalczyk, A.P. (2009). The desmosome. Cold Spring Harb. Perspect. Biol., 1.","DOI":"10.1101\/cshperspect.a002543"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/hrt.56.4.321","article-title":"Cardiac abnormalities in familial palmoplantar keratosis","volume":"56","author":"Protonotarios","year":"1986","journal-title":"Br. Heart J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1080\/14779072.2020.1828064","article-title":"Naxos disease\u2014A narrative review","volume":"18","author":"Leopoulou","year":"2020","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1161\/CIRCULATIONAHA.105.609719","article-title":"Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"113","author":"Entius","year":"2006","journal-title":"Circulation"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCGENETICS.114.001003","article-title":"Clinical presentation, long-term follow-up, and outcomes of 1001 arrhythmogenic right ventricular dysplasia\/cardiomyopathy patients and family members","volume":"8","author":"Groeneweg","year":"2015","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s13353-021-00647-y","article-title":"Pathogenic variants in plakophilin-2 gene (PKP2) are associated with better survival in arrhythmogenic right ventricular cardiomyopathy","volume":"62","author":"Biernacka","year":"2021","journal-title":"J. Appl. Genet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e003273","DOI":"10.1161\/CIRCGEN.120.003273","article-title":"International evidence based reappraisal of genes associated with arrhythmogenic right ventricular cardiomyopathy using the Clinical Genome Resource framework","volume":"14","author":"James","year":"2021","journal-title":"Circ. Genom. Precis. Med."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Alcalde, M., Campuzano, O., Berne, P., Garc\u00eda-Pav\u00eda, P., Doltra, A., Arbelo, E., Sarquella-Brugada, G., Iglesias, A., Alonso-Pulpon, L., and Brugada, J. (2014). Stop-gain mutations in PKP2 are associated with a later age of onset of arrhythmogenic right ventricular cardiomyopathy. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0100560"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Xu, Z., Zhu, W., Wang, C., Huang, L., Zhou, Q., Hu, J., Cheng, X., and Hong, K. (2017). Genotype-phenotype relationship in patients with arrhythmogenic right ventricular cardiomyopathy caused by desmosomal gene mutations: A systematic review and meta-analysis. Sci. Rep., 7.","DOI":"10.1038\/srep41387"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1086\/509044","article-title":"Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathy","volume":"79","author":"Heuser","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1093\/hmg\/ddr392","article-title":"Restrictive loss of plakoglobin in cardiomyocytes leads to arrhythmogenic cardiomyopathy","volume":"20","author":"Li","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.hrthm.2011.06.026","article-title":"Clinical phenotype and diagnosis of arrhythmogenic right ventricular cardiomyopathy in pediatric patients carrying desmosomal gene mutations","volume":"8","author":"Bauce","year":"2011","journal-title":"Heart Rhythm."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ajhg.2008.01.010","article-title":"Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene","volume":"82","author":"Merner","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/CIRCULATIONAHA.117.028719","article-title":"Novel Desmin mutation p.Glu401Asp impairs filament formation, disrupts cell membrane integrity, and causes severe arrhythmogenic left ventricular cardiomyopathy\/dysplasia","volume":"137","author":"Carriel","year":"2018","journal-title":"Circulation"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s12471-013-0413-z","article-title":"The phospholamban p.Arg14del founder mutation in Dutch patients with arrhythmogenic cardiomyopathy","volume":"21","author":"Hassink","year":"2013","journal-title":"Neth. Heart J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e001605","DOI":"10.1161\/CIRCGENETICS.116.001605","article-title":"Identification of cadherin 2 (CDH2) mutations in arrhythmogenic right ventricular cardiomyopathy","volume":"10","author":"Mayosi","year":"2017","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/cvr\/cvw234","article-title":"Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia\/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis","volume":"113","author":"James","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.cardiores.2004.10.005","article-title":"Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1","volume":"65","author":"Beffagna","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/eurheartj\/ehr451","article-title":"Mutations in the Lamin A\/C gene mimic arrhythmogenic right ventricular cardiomyopathy","volume":"33","author":"Quarta","year":"2012","journal-title":"Eur. Heart J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e003645","DOI":"10.1161\/CIRCGEN.121.003645","article-title":"Loss-of-function FLNC variants are associated with arrhythmogenic cardiomyopathy phenotypes when identified through exome sequencing of a general clinical population","volume":"15","author":"Carruth","year":"2022","journal-title":"Circ. Genom. Precis. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1042\/BST0360181","article-title":"Structural studies on desmosomes","volume":"36","author":"Frangakis","year":"2008","journal-title":"Biochem. Soc. Trans."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jdermsci.2006.10.006","article-title":"Discriminating roles of desmosomal cadherins: Beyond desmosomal adhesion","volume":"45","author":"Dusek","year":"2007","journal-title":"J. Dermatol. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1038\/sj.jid.5701015","article-title":"Desmosomes: New perspectives on a classic","volume":"127","author":"Green","year":"2007","journal-title":"J. Investig. Dermatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-pathol-020117-044030","article-title":"Desmosomes in human disease","volume":"13","author":"Najor","year":"2018","journal-title":"Annu. Rev. Pathol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/cvr\/cvx150","article-title":"Arrhythmogenic cardiomyopathy: Pathology, genetics, and concepts in pathogenesis","volume":"113","author":"Hoorntje","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Meraviglia, V., Alcalde, M., Campuzano, O., and Bellin, M. (2021). Inflammation in the pathogenesis of arrhythmogenic cardiomyopathy: Secondary event or active driver?. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.784715"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.5858\/arpa.2014-0114-RS","article-title":"A brief review and update of the clinicopathologic diagnosis of arrhythmogenic cardiomyopathy","volume":"139","author":"McGregor","year":"2015","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1093\/cvr\/cvaa084","article-title":"Arrhythmogenic cardiomyopathy: Pathogenesis, pro-arrhythmic remodelling, and novel approaches for risk stratification and therapy","volume":"116","author":"Basso","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"dev146589","DOI":"10.1242\/dev.146589","article-title":"Wnt signaling in development and tissue homeostasis","volume":"145","author":"Steinhart","year":"2018","journal-title":"Development"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"60640","DOI":"10.18632\/oncotarget.17457","article-title":"Wnt\/\u03b2-catenin pathway in arrhythmogenic cardiomyopathy","volume":"8","author":"Lorenzon","year":"2017","journal-title":"Oncotarget"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","article-title":"Wnt\/beta-catenin signaling: Components, mechanisms, and diseases","volume":"17","author":"MacDonald","year":"2009","journal-title":"Dev. Cell"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Gao, S., Puthenvedu, D., Lombardi, R., and Chen, S.N. (2020). Established and emerging mechanisms in the pathogenesis of arrhythmogenic cardiomyopathy: A multifaceted disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176320"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1126\/science.289.5481.950","article-title":"Inhibition of adipogenesis by Wnt signaling","volume":"289","author":"Ross","year":"2000","journal-title":"Science"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1083\/jcb.152.1.87","article-title":"Wnt-1 signaling inhibits apoptosis by activating beta-catenin\/T cell factor-mediated transcription","volume":"152","author":"Chen","year":"2001","journal-title":"J. Cell Biol."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Piquer-Gil, M., Domenech-Dauder, S., Sep\u00falveda-G\u00f3mez, M., Mach\u00ed-Camacho, C., Braza-Bo\u00efls, A., and Zorio, E. (2022). Non coding RNAs as regulators of Wnt\/\u03b2-catenin and Hippo pathways in arrhythmogenic cardiomyopathy. Biomedicines, 10.","DOI":"10.3390\/biomedicines10102619"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","article-title":"Hippo pathway in organ size control, tissue homeostasis, and cancer","volume":"163","author":"Yu","year":"2015","journal-title":"Cell"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12967-019-1869-4","article-title":"Analysis of the role of the Hippo pathway in cancer","volume":"17","author":"Han","year":"2019","journal-title":"J. Transl. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41392-022-01191-9","article-title":"The Hippo signalling pathway and its implications in human health and diseases","volume":"7","author":"Fu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.molcel.2016.10.034","article-title":"Characterization of Hippo pathway components by gene inactivation","volume":"64","author":"Plouffe","year":"2016","journal-title":"Mol. Cell"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/CIRCRESAHA.114.302810","article-title":"The hippo pathway is activated and is a causal mechanism for adipogenesis in arrhythmogenic cardiomyopathy","volume":"114","author":"Chen","year":"2014","journal-title":"Circ. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1126\/science.1199010","article-title":"Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size","volume":"332","author":"Heallen","year":"2011","journal-title":"Science"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"6404638","DOI":"10.1155\/2017\/6404638","article-title":"PPAR\u03b3 and its role in cardiovascular diseases","volume":"2017","author":"Chandra","year":"2017","journal-title":"PPAR Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nm.3159","article-title":"PPAR\u03b3 signaling and metabolism: The good, the bad and the future","volume":"19","author":"Ahmadian","year":"2013","journal-title":"Nat. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e748","DOI":"10.1002\/ctm2.748","article-title":"The PPAR\u03b3 pathway determines electrophysiological remodelling and arrhythmia risks in DSC2 arrhythmogenic cardiomyopathy","volume":"12","author":"Reisqs","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e14365","DOI":"10.15252\/emmm.202114365","article-title":"Oxidized LDL-dependent pathway as new pathogenic trigger in arrhythmogenic cardiomyopathy","volume":"13","author":"Sommariva","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"S286","DOI":"10.1016\/j.hrthm.2023.03.758","article-title":"Po-02-246 ppar\u03b3 activation mediates cardiac pathologies in two mouse models of arrhythmogenic cardiomyopathy (acm) and its therapeutic implications","volume":"20","author":"Wei","year":"2023","journal-title":"Heart Rhythm."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Lu, W., Rao, Y., Li, Y., Dai, Y., and Chen, K. (2022). The landscape of cell death processes with associated immunogenic and fibrogenic effects in arrhythmogenic cardiomyopathy. J. Cardiovasc. Dev. Dis., 9.","DOI":"10.3390\/jcdd9090301"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1056\/NEJM199610173351604","article-title":"Evidence of apoptosis in arrhythmogenic right ventricular dysplasia","volume":"335","author":"Mallat","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/cvr\/cvu212","article-title":"Arrhythmogenic right ventricular cardiomyopathy mutations alter shear response without changes in cell-cell adhesion","volume":"104","author":"Hariharan","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1161\/CIRCGENETICS.113.000188","article-title":"Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells","volume":"6","author":"Caspi","year":"2013","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1172\/JCI27751","article-title":"Suppression of canonical Wnt\/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy","volume":"116","author":"Lombardi","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1136\/jclinpath-2012-201022","article-title":"Arrhythmogenic right ventricular cardiomyopathy: Severe structural alterations are associated with inflammation","volume":"65","author":"Campuzano","year":"2012","journal-title":"J. Clin. Pathol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1161\/CIRCULATIONAHA.121.055890","article-title":"Inflammation and immune response in arrhythmogenic cardiomyopathy: State-of-the-art review","volume":"144","author":"Asatryan","year":"2021","journal-title":"Circulation"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e556","DOI":"10.1161\/CIRCULATIONAHA.110.960096","article-title":"Myocarditic appearance of arrhythmogenic right ventricular cardiomyopathy","volume":"122","author":"Jordan","year":"2010","journal-title":"Circulation"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Patrianakos, A.P., Protonotarios, N., Nyktari, E., Pagonidis, K., Tsatsopoulou, A., Parthenakis, F.I., and Vardas, P.E. (2012). Arrhythmogenic right ventricular cardiomyopathy\/dysplasia and troponin release. Myocarditis or the \u201chot phase\u201d of the disease?. Int. J. Cardiol., 157.","DOI":"10.1016\/j.ijcard.2011.09.017"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00380-008-1082-5","article-title":"Naxos disease presenting with ventricular tachycardia and troponin elevation","volume":"24","author":"Lazaros","year":"2009","journal-title":"Heart Vessel."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Monda, E., Palmiero, G., Rubino, M., Verrillo, F., Amodio, F., Di Fraia, F., Pacileo, R., Fimiani, F., Esposito, A., and Cirillo, A. (2020). Molecular basis of inflammation in the pathogenesis of cardiomyopathies. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186462"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10741-016-9536-9","article-title":"The fibrosis-cell death axis in heart failure","volume":"21","author":"Piek","year":"2016","journal-title":"Heart Fail. Rev."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00395-020-0803-5","article-title":"Inflammation shapes pathogenesis of murine arrhythmogenic cardiomyopathy","volume":"115","author":"Lubos","year":"2020","journal-title":"Basic. Res. Cardiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCEP.111.964890","article-title":"Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy","volume":"4","author":"Asimaki","year":"2011","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s12265-017-9767-8","article-title":"Arrhythmogenic cardiomyopathy: The guilty party in adipogenesis","volume":"10","author":"Stadiotti","year":"2017","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Vencato, S., Romanato, C., Rampazzo, A., and Calore, M. (2024). Animal models and molecular pathogenesis of arrhythmogenic cardiomyopathy associated with pathogenic variants in intercalated disc genes. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25116208"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00395-022-00929-4","article-title":"Fibro-fatty remodelling in arrhythmogenic cardiomyopathy","volume":"117","author":"Kohela","year":"2022","journal-title":"Basic. Res. Cardiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.tem.2014.04.001","article-title":"PPAR\u03b3 and the global map of adipogenesis and beyond","volume":"25","author":"Lefterova","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1210\/jc.2008-0574","article-title":"CCAAT\/enhancer binding protein alpha (C\/EBPalpha) in adipose tissue regulates genes in lipid and glucose metabolism and a genetic variation in C\/EBPalpha is associated with serum levels of triglycerides","volume":"93","author":"Olofsson","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"287","DOI":"10.5858\/2000-124-0287-MT","article-title":"Myocyte transdifferentiation","volume":"124","author":"Giordano","year":"2000","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s00380-008-1079-0","article-title":"Markedly increased intracellular lipid droplets and disruption of intercellular junctions in biopsied myocardium from a patient with arrhythmogenic right ventricular cardiomyopathy","volume":"23","author":"Fujita","year":"2008","journal-title":"Heart Vessel."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/hmg\/ddt508","article-title":"Connexin defects underlie arrhythmogenic right ventricular cardiomyopathy in a novel mouse model","volume":"23","author":"Lyon","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e98133","DOI":"10.15252\/embj.201798133","article-title":"Interplay of cell-cell contacts and RhoA\/MRTF-A signaling regulates cardiomyocyte identity","volume":"37","author":"Dorn","year":"2018","journal-title":"EMBO J."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.phrs.2017.07.020","article-title":"The epicardium as a source of multipotent adult cardiac progenitor cells: Their origin, role and fate","volume":"127","author":"Smits","year":"2018","journal-title":"Pharmacol. Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/cvr\/cvs219","article-title":"Intercalated disc abnormalities, reduced Na(+) current density, and conduction slowing in desmoglein-2 mutant mice prior to cardiomyopathic changes","volume":"95","author":"Rizzo","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1152\/physrev.00021.2022","article-title":"The intercalated disc: A unique organelle for electromechanical synchrony in cardiomyocytes","volume":"103","author":"Nielsen","year":"2023","journal-title":"Physiol. Rev."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1161\/CIRCULATIONAHA.113.003077","article-title":"Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype","volume":"129","author":"Cerrone","year":"2014","journal-title":"Circulation"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/cvr\/cvr252","article-title":"Biology of cardiac sodium channel Nav1.5 expression","volume":"93","author":"Rook","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/CIRCRESAHA.109.201418","article-title":"Loss of plakophilin-2 expression leads to decreased sodium current and slower conduction velocity in cultured cardiac myocytes","volume":"105","author":"Sato","year":"2009","journal-title":"Circ. Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.cardiores.2003.12.007","article-title":"Gap junction alterations in human cardiac disease","volume":"62","author":"Severs","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cardiores.2003.11.013","article-title":"Gap junctions and the connexin protein family","volume":"62","author":"Willecke","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1042\/BJ20082319","article-title":"Connexin43 phosphorylation: Structural changes and biological effects","volume":"419","author":"Solan","year":"2009","journal-title":"Biochem. J."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/CIRCRESAHA.107.154252","article-title":"Connexin43 remodeling caused by inhibition of plakophilin-2 expression in cardiac cells","volume":"101","author":"Oxford","year":"2007","journal-title":"Circ. Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1056\/NEJMoa0808138","article-title":"A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy","volume":"360","author":"Asimaki","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1161\/CIRCULATIONAHA.117.030792","article-title":"Risk stratification in arrhythmogenic right ventricular cardiomyopathy","volume":"136","author":"Calkins","year":"2017","journal-title":"Circulation"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/j.jacc.2003.03.002","article-title":"Does sports activity enhance the risk of sudden death in adolescents and young adults?","volume":"42","author":"Corrado","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijcard.2021.06.009","article-title":"Antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: The importance of optimal beta-blocker dose titration","volume":"338","author":"Gasperetti","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"ref_116","first-page":"229","article-title":"Arrhythmogenic right ventricular cardiomyopathy: Diagnosis, risk stratification, and treatment","volume":"122","author":"Kreimer","year":"2025","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1093\/eurheartj\/ehac289","article-title":"Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: External validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator","volume":"43","author":"Bosman","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_118","first-page":"1023","article-title":"New insights into genetic right ventricular cardiomyopathies","volume":"41","author":"Fanous","year":"2025","journal-title":"Can. J. Cardiol."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Lundstrom, K. (2018). Viral vectors in gene therapy. Diseases, 6.","DOI":"10.3390\/diseases6020042"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.omtm.2019.01.008","article-title":"Capsid modifications for targeting and improving the efficacy of AAV vectors","volume":"12","author":"Srivastava","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Mundisugih, J., Ravindran, D., and Kizana, E. (2024). Exploring the therapeutic potential of gene therapy in Arrhythmogenic Right Ventricular Cardiomyopathy. Biomedicines, 12.","DOI":"10.3390\/biomedicines12061351"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.stemcr.2021.12.016","article-title":"Modeling reduced contractility and impaired desmosome assembly due to plakophilin-2 deficiency using isogenic iPS cell-derived cardiomyocytes","volume":"17","author":"Inoue","year":"2022","journal-title":"Stem Cell Rep."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/s44161-023-00370-3","article-title":"Plakophilin 2 gene therapy prevents and rescues arrhythmogenic right ventricular cardiomyopathy in a mouse model harboring patient genetics","volume":"2","author":"Bradford","year":"2023","journal-title":"Nat. Cardiovasc. Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/s44161-023-00378-9","article-title":"Therapeutic efficacy of AAV-mediated restoration of PKP2 in arrhythmogenic cardiomyopathy","volume":"2","author":"Kyriakopoulou","year":"2023","journal-title":"Nat. Cardiovasc. Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s43856-024-00450-w","article-title":"AAV9:PKP2 improves heart function and survival in a Pkp2-deficient mouse model of arrhythmogenic right ventricular cardiomyopathy","volume":"4","author":"Wu","year":"2024","journal-title":"Commun. Med."},{"key":"ref_126","first-page":"e004305","article-title":"AAV-mediated delivery of plakophilin-2a arrests progression of arrhythmogenic right ventricular cardiomyopathy in Murine hearts: Preclinical evidence supporting gene therapy in humans","volume":"17","author":"Narayanan","year":"2024","journal-title":"Circ. Genom. Precis. Med."},{"key":"ref_127","unstructured":"Lexeo Therapeutics, Inc. (2025). Form 10-K, Annual Report for the Fiscal Year Ended December 31, 2024."},{"key":"ref_128","unstructured":"Therapeutics, T. (2025, October 08). Tenaya Therapeutics Provides Update on RIDGE-1 Gene Therapy Clinical Trial for PKP2-Associated ARVC. Tenaya Therapeutics Investor Relations. Available online: https:\/\/investors.tenayatherapeutics.com\/node\/8511\/pdf."},{"key":"ref_129","unstructured":"Rocket Pharmaceuticals, Inc. (2025, October 08). Rocket Pharmaceuticals Announces Preliminary Positive Results from Phase 1 Trial of RP-A601 for PKP2-Associated Arrhythmogenic Cardiomyopathy. Rocket Pharmaceuticals Investor Relations. Available online: https:\/\/ir.rocketpharma.com\/node\/12551\/pdf."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases","volume":"148","author":"Beurel","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Eldar-Finkelman, H., and Martinez, A. (2011). GSK-3 inhibitors: Preclinical and clinical focus on CNS. Front. Mol. Neurosci., 4.","DOI":"10.3389\/fnmol.2011.00032"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1074-5521(00)00025-9","article-title":"Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription","volume":"7","author":"Coghlan","year":"2000","journal-title":"Chem. Biol."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Snitow, M.E., Bhansali, R.S., and Klein, P.S. (2021). Lithium and therapeutic targeting of GSK-3. Cells, 10.","DOI":"10.3390\/cells10020255"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1113\/EP088061","article-title":"Low-dose lithium feeding increases the SERCA2a-to-phospholamban ratio, improving SERCA function in murine left ventricles","volume":"105","author":"Hamstra","year":"2020","journal-title":"Exp. Physiol."},{"key":"ref_135","first-page":"gad453","article-title":"Mechanisms for cardiac calcium pump activation by its substrate and a synthetic allosteric modulator using fluorescence lifetime imaging","volume":"3","author":"Robia","year":"2024","journal-title":"PNAS Nexus"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"e85923","DOI":"10.1172\/jci.insight.85923","article-title":"Central role for GSK3\u03b2 in the pathogenesis of arrhythmogenic cardiomyopathy","volume":"1","author":"Chelko","year":"2016","journal-title":"JCI Insight"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/11\/1512\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:24:10Z","timestamp":1761535450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/11\/1512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,25]]},"references-count":136,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["biom15111512"],"URL":"https:\/\/doi.org\/10.3390\/biom15111512","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,25]]}}}